healthcare will play an increasing role in shaping the future of care delivery, particularly as payers, especially employers, reassess the cost-effectiveness of pharmaceutical interventions relative to traditional medical procedures
New Evidence on GLP-1 Receptor Agonists and Acute Pancreatitis Risk Exciting findings just published in The American Journal of Gastroenterology address a long-standing safety concern around GLP-1 receptor agonists (GLP-1 RAs) in type 2 diabetes: A multicenter, real-world analysis of more than 40,000 matched patients using the TriNetX network showed no increased risk of acute pancreatitis in GLP-1 RA users compared to non-users
Just a medical team helping you think a few steps ahead, knowing the predictable aesthetic outcomes of weight loss medication
Researchers recommend that doctors have a deep understanding of someones mental health before that person starts a GLP-1 medication
Sleep & Circadian Research: GH release during deep sleep is a major area of investigation with this combination
With our Synergy Network, you get high-quality care close to home to cover all of Oregon, Southern Washington, and Idaho
